Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ramalingam

Showing results (31-40 of 502) with videos related to

Pageof 51
Sort By:
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|November 25, 2011
Vibrational spectroscopic investigation (FT-IR and FT-Raman) on 1,2-dibromobenzene by HF and hybrid (LSDA and B3LYP) calculationsG Shakila, S Periandy, S Ramalingam
JTO Clinical and Research Reports|September 30, 2021
<i>RET</i> Fusion: Joining the Ranks of Targetable Molecular Drivers in NSCLCBadi El Osta, Suresh S Ramalingam
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|December 25, 2010
Molecular structure and vibrational analysis of 3-Ethylpyridine using ab initio HF and density functional theory (B3LYP) calculationsG Shakila, S Periandy, S Ramalingam
JCO Oncology Practice|June 25, 2021
Advances in Immunotherapy and Implications for Current Practice in Non-Small-Cell Lung CancerConor E Steuer, Suresh S Ramalingam
Cancer|May 24, 2014
ALK-positive non-small cell lung cancer: mechanisms of resistance and emerging treatment optionsConor E Steuer, Suresh S Ramalingam
Current Opinion in Oncology|January 28, 2014
Heat shock protein 90 inhibitors in non-small-cell lung cancerRathi N Pillai, Suresh S Ramalingam
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Recent advances in the treatment of malignant pleural mesotheliomaSuresh S Ramalingam, Chandra P Belani
The Oncologist|April 4, 2009
The role of the taxanes in the treatment of older patients with advanced stage non-small cell lung cancerSuresh S Ramalingam, Fadlo R Khuri
Heliyon|March 11, 2020
Structural, biological and pharmaceutical importance of antibiotic agent chloramphenicolA Sathya, T Prabhu, S Ramalingam
Cell Reports. Medicine|July 20, 2022
Neoadjuvant therapy gains FDA approval in non-small cell lung cancerTiciana A Leal, Suresh S Ramalingam
Pageof 51

Showing results (31-40 of 502) with videos related to

Sort By:
Pageof 51
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|November 25, 2011
Vibrational spectroscopic investigation (FT-IR and FT-Raman) on 1,2-dibromobenzene by HF and hybrid (LSDA and B3LYP) calculationsG Shakila, S Periandy, S Ramalingam
JTO Clinical and Research Reports|September 30, 2021
<i>RET</i> Fusion: Joining the Ranks of Targetable Molecular Drivers in NSCLCBadi El Osta, Suresh S Ramalingam
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|December 25, 2010
Molecular structure and vibrational analysis of 3-Ethylpyridine using ab initio HF and density functional theory (B3LYP) calculationsG Shakila, S Periandy, S Ramalingam
JCO Oncology Practice|June 25, 2021
Advances in Immunotherapy and Implications for Current Practice in Non-Small-Cell Lung CancerConor E Steuer, Suresh S Ramalingam
Cancer|May 24, 2014
ALK-positive non-small cell lung cancer: mechanisms of resistance and emerging treatment optionsConor E Steuer, Suresh S Ramalingam
Current Opinion in Oncology|January 28, 2014
Heat shock protein 90 inhibitors in non-small-cell lung cancerRathi N Pillai, Suresh S Ramalingam
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Recent advances in the treatment of malignant pleural mesotheliomaSuresh S Ramalingam, Chandra P Belani
The Oncologist|April 4, 2009
The role of the taxanes in the treatment of older patients with advanced stage non-small cell lung cancerSuresh S Ramalingam, Fadlo R Khuri
Heliyon|March 11, 2020
Structural, biological and pharmaceutical importance of antibiotic agent chloramphenicolA Sathya, T Prabhu, S Ramalingam
Cell Reports. Medicine|July 20, 2022
Neoadjuvant therapy gains FDA approval in non-small cell lung cancerTiciana A Leal, Suresh S Ramalingam
Pageof 51